Expert Review of Hematology

血液学专家评审

EXPERT REV HEMATOL

影响因子：2.1

JCR分区：Q3

新锐分区：医学4区

是否综述期刊：N/A

是否预警：不在预警名单内

是否OA：否

出版国家/地区：ENGLAND

出版社：Taylor and Francis Ltd.

发刊时间：2008

收录数据库：SCIE/Scopus收录

ISSN：1747-4086

期刊介绍

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.

血液学专家评审近年来，先进的分子研究技术已经改变了血液学。随着对血液病认识的提高，我们现在有机会研究和评估新的生物疗法、新的药物和药物组合、新的治疗方案和新的方法，包括干细胞移植。我们还可以期待蛋白质组学、分子遗传学和生物标志物研究促进新的诊断方法和适当疗法的确定。我们对血细胞和造血组织的形成和功能的认识将继续取得进一步的进展，对血液学家来说，采用这些新的范式并制定综合策略来定义最佳的患者护理将是一个重大挑战。《血液学专家评论》（1747-4086）将这些进展置于背景中，并探讨了它们将如何直接转化为临床实践。

年发文量 91

国人发稿量 2.73

国人发文占比 0.03%

自引率 0%

平均录取率较易

平均审稿周期较慢,6-12周

版面费 -

偏重研究方向 HEMATOLOGY-

期刊官网 http://www.tandfonline.com/toc/ierr20/current

投稿链接 https://mc.manuscriptcentral.com/ehm